Keyword: Bob Kennedy Thomson Reuters

GDUFA: Who Will Benefit?

13.01.2012 - The pharmaceutical supply chain is increasingly globalized. It is estimated that 80% of the active ingredients used in generic medicines marketed in the U.S. are manufactured in...

Plant Construction & Process Technology

API Sourcing in China and India

19.10.2011 - Paradigm Shift - The number of API manufacturers in India and China focused on supplying active ingredients to regulated markets has grown considerably over the past few years...